What's new in atopic eczema? An analysis of systematic reviews published in 2010-11

Clinical and Experimental Dermatology

Volumn 38, Issue 5, 2013, Pages 449-456

  Torley, D ^a   Futamura, M ^b,c   Williams, H C ^b   Thomas, K S ^b  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COAL TAR; EFALIZUMAB; FLUTICASONE PROPIONATE; METHYLPREDNISOLONE ACEPONATE; OMEGA 3 FATTY ACID; PETROLATUM; PIMECROLIMUS; PREBIOTIC AGENT; PROBIOTIC AGENT; SALICYLIC ACID; TACROLIMUS;

ALLERGIC ASTHMA; ANAPHYLAXIS; ATOPIC DERMATITIS; CELLULAR IMMUNITY; CHINESE MEDICINE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FOOD ALLERGY; HOMEOPATHY; HUMAN; IMMUNOTHERAPY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MENINGIOMA; NONHUMAN; PATIENT EDUCATION; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHINOCONJUNCTIVITIS; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC);

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; COMPLEMENTARY THERAPIES; DERMATITIS, ATOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RISK FACTORS;

EID: 84879242136     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12143     Document Type: Review

References (34)

1. Williams HC, Grindlay DJC,. What's new in atopic eczema? An analysis of the clinical significance of systematic reviews on atopic eczema published in 2006 and 2007. Clin Exp Dermatol 2008; 33: 685-8.
2. Williams HC, Grindlay DJC,. What's new in atopic eczema? An analysis of the clinical significance of systematic reviews on atopic eczema published in 2007 and 2008. Part 1. Definitions, causes, and consequences of eczema. Clin Exp Dermatol 2010; 35: 12-15.
3. Williams HC, Grindlay DJC,. What's new in atopic eczema? An analysis of the clinical significance of systematic reviews on atopic eczema published in 2007 and 2008. Part 2. Disease prevention and treatment. Clin Exp Dermatol 2010; 35: 223-7.
4. Batchelor JM, Grindlay DJC, Williams HC,. What's new in atopic eczema? An analysis of systematic reviews published in 2008 and 2009. Clin Exp Dermatol 2010; 35: 823-8.
5. Shams K, Grindlay DJC, Williams HC,. What's new in atopic eczema? An analysis of the clinical significance of systematic reviews published in 2009-10. Clin Exp Dermatol 2011; 36: 573-8.
6. Flohr C, Yeo L,. Atopic dermatitis and the hygiene hypothesis revisited. Curr Probl Dermatol 2011; 41: 1-34.
7. Flohr C, Pascoe D, Williams HC,. Atopic dermatitis and the hygiene hypothesis: too clean to be true? Br J Dermatol 2005; 152: 202-16.
8. Arnoldussen DL, Linehan M, Sheikh ABCG,. vaccination and allergy. A systematic review and meta-analysis. J Allergy Clin Immunol 2011; 127: 246-53.
9. Tishcer C, Chen CM, Heinrich J,. Assocation between domestic mould and mould components, and asthma and allergy in children: a systematic review. Eur Respir J 2011; 38: 812-24.
10. Mendell MJ, Mirer AG, Cheung K, et al,. Respiratory and allergic health effects of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence. Environ Health Perspect 2011; 119: 748-56.
11. Patelarou E, Giourgouli G, Lykeridou A, et al,. Association between biomarker-quantified antioxidant status during pregnancy and infancy and allergic disease during early childhood: a systematic review. Nutr Rev 2011; 69: 627-41.
12. Wang M, Chen C, Qu J, et al,. Inverse association between eczema and meningioma: a meta-analysis. Cancer Causes Control 2011; 22: 1355-63.
13. Foisy M, Boyle RJ, Chalmers JR, et al,. The prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews. Evid Based Child Health 2011; 6: 1322-39.
14. Klemens CM, Bermand DR, Mozurkewich EL,. The effect of perinatal omega-3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review. BJOG 2011; 118: 916-25.
15. Makrides M, Gibson RA, McPhee AJ, et al,. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010; 304: 1675-83.
16. Braegger C, Chmielewska A, Decsi T, et al,. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by ESPGHAN committee nutrition. J Pediatr Gastroenterol Nutr 2011; 52: 238-50.
17. Zhu DL, Yang WX, Yang HM,. Meta analysis of lactic acid bacteria as probiotics for the primary prevention of infantile eczema. Zhongguo Dang Dai Er Ke Za Zhi 2010; 12: 734-9.
18. De Bes J, Legierse CM, Prinsen CAC, et al,. Patient education in chronic skin diseases: a systematic review. Acta Derm Venereol 2011; 91: 12-17.
19. Ahnert J, Muller J, Loffler S, et al,. Patients and parents education in atopic neurodermatitis. Evidence-based literature analysis of the impact of rehabilitation of children and adolescents with neurodermatitis. Monatsschr Kinderheilkd 2010; 158: 586-91.
20. Williams HC,. Preventing eczema flares with topical corticosteroids or tacrolimus: which is best? Br J Dermatol 2011; 164: 231-3.
21. Schmitt J, Von Kobyletzki L, Svensson A, et al,. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol 2010; 164: 415-28.
22. Yin Z, Xu J, Luo D,. Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis. J Biomed Res 2011; 25: 385-91.
23. Svensson A, Chambers C, Ganemo A, et al,. A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis. Curr Med Res Opin 2011; 27: 1395-406.
24. Slutsky JB, Clark AF, Remedios AA, et al,. An evidence-based review of the efficacy of coal tar preparations in the treatment of psoriasis and atopic dermatitis. J Drugs Dermatol 2010; 9: 1258-64.
25. Schram ME, Borgonjen RJ, Bik CMJM, et al,. Off-label use of azathioprine in dermatology. Arch Dermatol 2011; 147: 474-88.
26. Schram ME, Spuls PI, Bos JD,. Off- label use of efalizumab in dermatology. Expert Rev Dermatol 2010; 5: 535-47.
27. Pajno GB, Finegold I,. SIT beyond respiratory disease. Ann Allergy Asthma Immunol 2011; 107: 395-400.
28. Simonart T, Kabagabo C, De Maerelaer V,. Homeopathic remedies in dermatology: a systematic review of controlled clinical trials. Br J Dermatol 2011; 165: 897-905.
29. Reuter J, Merfort I, Schempp CM,. Botanicals in dermatology-an evidence based review. Am J Clin Dermatol 2010; 11: 247-67.
30. Hon KL, Chan BCL, Leung PC,. Chinese herbal medicine research in eczema treatment. Chin Med 2011; 6: 17.
31. Scottish Intercollegiate Guidelines Network. Management of atopic eczema in primary care, March 2011. Available at: http://www.sign.ac.uk/pdf/sign125 (accessed November 2012).
32. National Institute of Health and Clinical Excellence. Review of clinical guideline. Management of atopic eczema in children. Available at: http://guidance.nice.org.uk/CG57/ReviewDecision/pdf/English (accessed November 2012).
33. Royal College of Paediatrics and Child Health. Eczema care pathway 2011. Available at: http://www.rcpch.ac.uk/allergy/eczema (accessed November 2012).
34. Rehal B, Armstrong A,. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality of life instruments, 1985-2010. PLoS One 2011; 6: 1-7.